Royal Peptides products are offered exclusively for laboratory research, analytical, and scientific applications. Not for human or veterinary use.
01Research Product Information
Royal Peptides supplies compounds intended for controlled laboratory research and analytical applications.
- For research and analytical use only
- Not intended for human consumption or administration
- Not intended for veterinary use
- Not represented as a drug, medicine, or therapeutic product
- Laboratory researchers are responsible for appropriate protocols and controls
02Lyophilized Product Format
Where applicable, Royal Peptides research materials are supplied in lyophilized form.
Lyophilization is a freeze-drying process used to remove moisture from material under controlled conditions.
- Material appearance may differ between compounds and production lots
- Lyophilized material may appear as a cake, film, or fragmented material
- The quantity of visible material may appear small relative to vial size
- Visual appearance alone does not establish identity or purity
03Storage & Laboratory Handling
Storage requirements may vary by compound, formulation, and production lot. Refer to the product label and available product-specific documentation.
- Protect research materials from excessive heat
- Limit unnecessary exposure to direct light and moisture
- Keep containers securely closed when stored
- Follow product-specific temperature requirements when provided
- Use appropriate laboratory contamination-control procedures
04Packaging & Quality Documentation
Packaging components may vary slightly between production lots. This can include vial closures, cap styles, label positioning, and external packaging.
- Check the product label and lot identifier before laboratory use
- Inspect the vial and closure for visible shipping damage
- Packaging design may differ between batches
- Lot-specific analytical documentation may be available in our COA library
PT-141 10mg
PT-141 10mg – PT-141 Research Peptide
PT-141 10mg ships from U.S. stock at Royal Peptides – Bremelanotide Research Vials, with a lot-matched COA. PT-141 (bremelanotide) is a cyclic melanocortin agonist derived from Melanotan II and acts centrally rather than vascularly. Compare it with order melanotan research vials if your model involves MC1R.
PT-141, also known as bremelanotide, is a synthetic peptide research material supplied by Royal Peptides exclusively for legitimate laboratory, analytical, and scientific research applications.
Research Use Only
Not for human or veterinary use, administration, ingestion, injection, compounding, diagnostic, therapeutic, clinical, or personal use.

Order Online
Buy PT-141 10mg Online
Pick your strength with the selector at the top of this page and add PT-141 10mg to your cart. Prices are per vial or per kit as shown, and every order ships with lot documentation.
Buying more than one vial? Volume pricing applies automatically in the cart: 5% off at 3 vials and 10% off at 6 or more.
01
Compound Profile
PT-141 / Bremelanotide
PT-141 is a research designation associated with bremelanotide in scientific and pharmaceutical reference materials.
The names PT-141 and bremelanotide are presented on this page for compound identification, scientific reference, analytical documentation, and research cataloging purposes.
Royal Peptides supplies this product strictly as a laboratory research material. Information appearing on this page is not intended as clinical, therapeutic, diagnostic, preventive, veterinary, or personal-use guidance.
02
Identification
Research Material Profile
Accurate identification and lot documentation are important when peptide materials are incorporated into controlled analytical and experimental workflows.
03
Research Environment
Controlled Laboratory Applications
Royal Peptides PT-141 is supplied for professional research environments requiring appropriately identified peptide material for analytical, experimental, or reference-based laboratory work.
Analytical Chemistry
Suitable for appropriately designed laboratory workflows involving analytical evaluation and material characterization.
Compound Identification
Supports reference-based identification, comparative analysis, and organized laboratory evaluation.
Chromatographic Analysis
Laboratories may independently evaluate research materials using appropriate chromatographic methodologies.
Spectrometric Analysis
Appropriate analytical instrumentation may support independent compound identification and research-material characterization.
Stability Investigation
Controlled laboratory protocols may evaluate material characteristics under defined and documented experimental conditions.
Research Documentation
Batch information and analytical records help support organized laboratory documentation and material traceability.
04
Quality Documentation
Batch-Specific Analytical Information
Researchers should evaluate documentation associated with the specific production lot incorporated into their laboratory work.
General product descriptions should not replace applicable batch-specific analytical records.
- Compound identification
- PT-141 / Bremelanotide reference
- Batch or lot identification
- Analytical testing information
- Purity information where applicable
- Testing methodology where documented
- Certificate of Analysis information
- Batch-specific laboratory records
05
Research Traceability
Lot Control & Laboratory Records
Maintaining accurate material records helps laboratories associate analytical observations with the specific research lot incorporated into an experimental workflow.
Lot Identification
Record the compound name, product reference, applicable production lot, and material receipt information.
Analytical Records
Preserve applicable analytical documentation, laboratory observations, storage records, and internal research references.
06
Laboratory Protocol
Handling & Storage
Professional Laboratory Handling
PT-141 research material should be handled by individuals familiar with laboratory procedures, research-material identification, contamination control, and applicable laboratory safety practices.
Laboratory Storage
Researchers should follow storage information associated with the applicable product or batch documentation and maintain appropriate inventory and storage records.
07
Product Clarification
PT-141 Research Material Status
PT-141 and bremelanotide are names encountered in scientific, regulatory, and pharmaceutical reference materials.
Important Product Distinction
The PT-141 research material offered by Royal Peptides is not represented as Vyleesi® or as any other FDA-approved finished prescription drug product. References to PT-141 or bremelanotide are provided for compound identification and scientific reference only.
08
Research Restrictions
What This Material Is Not Intended For
Royal Peptides PT-141 is not offered or represented as a medicine, supplement, prescription preparation, food, cosmetic, or consumer health product.
- Not for human administration
- Not for veterinary administration
- Not for ingestion
- Not for injection
- Not for personal experimentation
- Not for pharmaceutical compounding
- Not for pharmacy preparation
- Not for diagnostic or therapeutic use
09
Research FAQ
PT-141 Research Questions
What is PT-141?
PT-141 is a research designation associated with the peptide compound bremelanotide. Royal Peptides supplies this material exclusively for legitimate laboratory and analytical research.
Is PT-141 also known as Bremelanotide?
Yes. PT-141 is a name associated with bremelanotide in scientific and regulatory reference materials. Both names are included here for compound-identification purposes.
Is Royal Peptides PT-141 intended for human use?
No. Royal Peptides PT-141 is supplied strictly for laboratory research and is not intended for human or veterinary use.
Is Royal Peptides PT-141 Vyleesi?
No. The Royal Peptides PT-141 research material offered on this page is not represented as Vyleesi or as an FDA-approved finished drug product.
Does Royal Peptides provide PT-141 dosing instructions?
No. Royal Peptides does not provide dosing, administration, injection, prescribing, treatment, or personal-use instructions for this research material.
Can this research material be used for compounding?
This product is not offered or represented for pharmaceutical compounding, pharmacy preparation, clinical preparation, or administration.
Is analytical documentation available?
Batch-specific analytical documentation may be available depending on the applicable production lot. Researchers should review documentation associated with the specific material received.
Why is lot traceability important?
Analytical documentation corresponds to a particular production lot. Maintaining the applicable lot reference supports traceability between the research material, analytical documentation, and laboratory records.
Quality Documentation
PT-141 10mg Lot Testing & COA
Every PT-141 10mg lot is independently tested before release; results are listed with our coas peptides. For background reading, see published PT-141 research on PubMed.
Related Research
Researchers Also Order
Compounds often studied alongside PT-141:



Buying Questions
Buying PT-141 10mg
Where can I buy PT-141 10mg?
Order PT-141 10mg directly from Royal Peptides. Choose a format in the Buy section, check out securely and your order ships from U.S. stock with lot documentation.
How fast do orders ship?
Orders are dispatched from U.S. inventory, usually within one business day, with tracking.
PT-141 for Laboratory Research
PT-141 10mg is supplied for laboratory research use only. Not for human or veterinary use.
Specifications
Product information pulled directly from WooCommerce.
COA / Testing
Independent third-party lab reports for this compound. Each report applies to the batch shown.
Shipping & Storage
Shipping options and delivery estimates are shown at checkout. Refer to the product label for storage requirements.
Related Research Materials.




